Neuberger Berman Group »

Vanda Pharmaceuticals shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $66k 11k 6.12
2018-09-30 $1.0M 46k 22.95
2018-06-30 $572k 30k 19.07

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Vanda Pharmaceuticals

BlackRock
AQR Capital Management
Renaissance Technologies
State Street Corporation
Vanguard Capital Management
AIGH Capital Management
Acadian Asset Management
Dimensional Fund Advisors
Millennium Management
Geode Capital Management
Two Sigma Investments
Marshall Wace
Jacobs Levy Equity Management
Krensavage Asset Management
Vanguard Portfolio Management

View all funds holding Vanda Pharmaceuticals